These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


419 related items for PubMed ID: 27764976

  • 1. Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy.
    Yoon CY, Chang TI, Kang EW, Lim BJ, Kie JH, Kee YK, Kim H, Park S, Yun HR, Jung SY, Jhee JH, Kwon YE, Oh HJ, Park JT, Yoo TH, Kang SW, Jeong HJ, Han SH.
    Ann Med; 2017 May; 49(3):217-229. PubMed ID: 27764976
    [Abstract] [Full Text] [Related]

  • 2. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.
    Bagchi S, Singh G, Yadav R, Kalaivani M, Mahajan S, Bhowmik D, Dinda A, Agarwal SK.
    Ren Fail; 2016 May; 38(3):431-6. PubMed ID: 26837482
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of immunosuppression in IgA nephropathy based on the oxford classification.
    Palamuthusingam D, Castledine C, Lawman S.
    Saudi J Kidney Dis Transpl; 2018 May; 29(2):341-350. PubMed ID: 29657202
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.
    Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J, Roberts IS, Morando L, Camilla R, Tesar V, Lunberg S, Gesualdo L, Emma F, Rollino C, Amore A, Praga M, Feriozzi S, Segoloni G, Pani A, Cancarini G, Durlik M, Moggia E, Mazzucco G, Giannakakis C, Honsova E, Sundelin BB, Di Palma AM, Ferrario F, Gutierrez E, Asunis AM, Barratt J, Tardanico R, Perkowska-Ptasinska A, VALIGA study of the ERA-EDTA Immunonephrology Working Group.
    Kidney Int; 2014 Oct; 86(4):828-36. PubMed ID: 24694989
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Predictors of Progression in IgA Nephropathy in Childhood.
    Mizerska-Wasiak M, Małdyk J, Turczyn A, Cichoń-Kawa K, Rybi-Szumińska A, Wasilewska A, Bieniaś B, Zajączkowska M, Miklaszewska M, Pietrzyk J, Demkow U, Roszkowska-Blaim M, Pańczyk-Tomaszewska M.
    Adv Exp Med Biol; 2017 Oct; 955():65-73. PubMed ID: 27718216
    [Abstract] [Full Text] [Related]

  • 10. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
    Wu H, Xia Z, Gao C, Zhang P, Yang X, Wang R, Wang M, Peng Y.
    BMC Nephrol; 2020 Jul 01; 21(1):247. PubMed ID: 32611399
    [Abstract] [Full Text] [Related]

  • 11. Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.
    Tesar V, Troyanov S, Bellur S, Verhave JC, Cook HT, Feehally J, Roberts IS, Cattran D, Coppo R, VALIGA study of the ERA-EDTA Immunonephrology Working Group.
    J Am Soc Nephrol; 2015 Sep 01; 26(9):2248-58. PubMed ID: 25677392
    [Abstract] [Full Text] [Related]

  • 12. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.
    Bellur SS, Roberts ISD, Troyanov S, Royal V, Coppo R, Cook HT, Cattran D, Arce Terroba Y, Asunis AM, Bajema I, Bertoni E, Bruijn JA, Cannata-Ortiz P, Casartelli D, Maria Di Palma A, Ferrario F, Fortunato M, Furci L, Gakiopoulou H, Galesic Ljubanovic D, Giannakakis K, Gomà M, Gröne HJ, Gutiérrez E, Asma Haider S, Honsova E, Ioachim E, Karkoszka H, Kipgen D, Maldyk J, Mazzucco G, Orhan D, Ozluk Y, Pantzaki A, Perkowska-Ptasinska A, Riispere Z, Soderberg MP, Steenbergen E, Stoppacciaro A, Sundelin Von Feilitzen B, Tardanico R.
    Nephrol Dial Transplant; 2019 Oct 01; 34(10):1681-1690. PubMed ID: 30561721
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.
    Chakera A, MacEwen C, Bellur SS, Chompuk LO, Lunn D, Roberts ISD.
    J Nephrol; 2016 Jun 01; 29(3):367-375. PubMed ID: 26318019
    [Abstract] [Full Text] [Related]

  • 14. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG, Araújo SA, Bambirra EA, Oliveira EA, Simões E Silva AC, Pinheiro SVB.
    J Pediatr (Rio J); 2017 Jun 01; 93(4):389-397. PubMed ID: 28130969
    [Abstract] [Full Text] [Related]

  • 15. Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
    Bellur SS, Lepeytre F, Vorobyeva O, Troyanov S, Cook HT, Roberts IS, International IgA Nephropathy Working Group.
    Kidney Int; 2017 Jan 01; 91(1):235-243. PubMed ID: 27914703
    [Abstract] [Full Text] [Related]

  • 16. Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy.
    Yu F, Zhu X, Yuan S, Chen X, Li Z, Qu Z, Liu H, Sun L, Liu F.
    Ann Med; 2021 Dec 01; 53(1):587-595. PubMed ID: 33825605
    [Abstract] [Full Text] [Related]

  • 17. The use of the Oxford classification of IgA nephropathy to predict renal survival.
    Alamartine E, Sauron C, Laurent B, Sury A, Seffert A, Mariat C.
    Clin J Am Soc Nephrol; 2011 Oct 01; 6(10):2384-8. PubMed ID: 21885791
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž, Laurinavičius A, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    Medicina (Kaunas); 2016 Oct 01; 52(6):340-348. PubMed ID: 27932191
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.